Author :   Kudryavets Yu.I.

APPLICATION OF ERBISOL^® ULTRAPHARM FOR THE TREATMENT OF PATIENTS WITH PANCREATIC CANCER

Authors:Zhylchuk A.V. Коrnilina Е.М. Kudryavets Yu.I. Maksymiak G.I. ... №21 1 2019 115

MODIFICATION OF EPITHELIAL-MESENCHYMAL TRANSITION IN BREAST CANCER CELLS BY MEANS OF THEIR CO-CULTIVATION WITH FIBROBLASTS AND BONE MARROW CELLS

Authors:Bezdenezhnykh N.O. Semesiuk N.I. Lykhova O.O. Zhylchuk V.E. ... №15 3 2013 1

THE EXPRESSION OF MARKERS OF EPITHELIAL-MESENCHYMAL TRANSITION AND DRUG RESISTANCE PROTEINS AS A PROGNOSTIC INDICATOR IN PATIENTS WITH COLORECTAL CANCER

Authors:Bezdieniezhnykh N.O. Zhylchuk V.E. Glanko M.V. Adamenko I.M. ... №18 1 2016 9

MICROENVIRONMENT OF TUMOR CELLS AS A SOURCE OF MODIFIERS OF EPITHELIAL-MESENCHYMAL TRANSITION AND TARGET FOR PERSONALIZED ANTICANCER THERAPY

Authors:Kudryavets Yu.I. Bezdieniezhnykh N.O. Semesyuk N.I. Zhylchuk A.V. ... №18 4 2016 3

APPLICATION OF ERBISOL® ULTRAPHARM FOR THE TREATMENT OF PATIENTS WITH PANCREATIC CANCER

Authors:Maksymiak G.I. Zhylchuk V.E. Zhylchuk A.V. Kudryavets Yu.I. ... №21 1 2019 18

INHIBITING INFLUENCE OF INTERFERON- ALPHA ON THE LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN BLOOD SERUM OF BREAST CANCER PATIENTS UNDERGOING COMBINED THERAPY

Authors:Lisnyak I.I. Kudryavets Yu.I. №10 3 2008 No views